Canada - English - Health Canada

apotex inc - telmisartan - tablet - 80mg - telmisartan 80mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

teva canada limited - telmisartan - tablet - 40mg - telmisartan 40mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

teva canada limited - telmisartan - tablet - 80mg - telmisartan 80mg - angiotensin ii receptor antagonists

Malta - English - Medicines Authority

bristol laboratories limited - telmisartan - tablet - telmisartan 20 milligram(s) - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

bristol laboratories limited - telmisartan - tablet - telmisartan 40 milligram(s) - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

bristol laboratories limited - telmisartan - tablet - telmisartan 80 milligram(s) - agents acting on the renin-angiotensin system

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan apel is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan apel is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: mannitol; meglumine; magnesium stearate; sodium hydroxide; sodium stearylfumarate; povidone - telmisartan alsa is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan alsa is indicated for: -treatment of hypertension -prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)